Methylation of cfDNA in Diagnosing and Monitoring Pulmonary Nodule

CompletedOBSERVATIONAL
Enrollment

401

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Pulmonary Nodule, Solitary
Interventions
PROCEDURE

plasma cfDNA methylation

plasma cfDNA will be performed in patients with pulmonary nodules (0.5-3 cm) found by CT scanning. Evaluation of benign and malignant diagnostic efficacy of cfDNA methylation in pulmonary nodules with clear pathological findings. Pulmonary nodules that could not or temporarily not require invasive examination will be performed CT follow-up and dynamically monitored methylation changes of cfDNA.

Trial Locations (1)

200030

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
lead

Jiayuan Sun

OTHER

NCT03989219 - Methylation of cfDNA in Diagnosing and Monitoring Pulmonary Nodule | Biotech Hunter | Biotech Hunter